Dr. Nader Ghasemlou
Dr. Nader Ghasemlou leads the Pain Chronobiology & Neuroimmunology Lab at Queen’s University, a multi-disciplinary research team studying the contribution of the cellular and molecular immune response to diseases of the nervous system, including inflammatory/neuropathic pain, multiple sclerosis, and spinal cord injury. His team uses a reverse-translational model to study disease, with clinical data informing fundamental animal studies with the goal of identifying new therapeutic targets. His group uses the body's internal clock (or chronobiological rhythms) that modulate up to 50% of genes and most physiological processes to identify potential mediators of disease. This work is made possible through multiple collaborations with patient-partners, psychologists, and chronic pain clinicians. Dr. Ghasemlou completed his Postdoctoral Fellowship (2009-2014) as a Banting Fellow at Harvard Medical School where he studied inflammatory and neuropathic pain in Dr. Clifford Woolf's lab. He carried out his doctoral studies in Neuroimmunology at McGill University (2002-2008) under the supervision of Dr. Samuel David, where he studied neuro-immune interactions in the spinal cord causing tissue damage.
DR. JOHN PEREIRA
Dr. John Xavier Pereira is the Immediate Past President of the Pain Society of Alberta and was a Founding Co-Chair of the Alberta Pain Strategy. He is a past Ronald Melzack Fellow of the McGill Pain Center and has spoken on the topic of chronic pain both nationally and internationally, including at the Centers for Disease Control, ANZCA Auckland, Massachusetts General Hospital, and the Mayo Clinic. He represented Western Canada on the committee of physicians who wrote our country’s National Guidelines for the diagnosis and treatment of fibromyalgia. Dr. John Pereira was the physician lead of FibroFOCUS, an interdisciplinary chronic pain program that won a 2016 Patient Experience Award from the Health Quality Council of Alberta. He is a member of the Canadian Pain Task Force's External Advisory Panel and has personally visited more than fifty pain clinics worldwide to learn best practices.